GL1X · GenesisL1 explorer

Research workbench

Catalytic domain of human phosphodiesterase 4B in complex with sildenafil

Analyse Catalytic domain of human phosphodiesterase 4B in complex with sildenafil in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1XOS
Type
protein
Length
322 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp-specific 3',5'-cyclic phosphodiesterase 4B
EC
3.1.4.17
UniProt
Q07343
Ligands
VIA, ZN, MG, SO4
Pockets
3 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 66% helix, 1% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACamp-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.17)protein32266% helix, 1% strandQ07343

Ligands and binding sites

  • VIA · 5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • MG · Magnesium ion · metal · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13880.730.8439MG, SO4, VIA
2540.310.7613empty
3520.280.7514empty

Modifications

Observed in the structure: 3 modified (artifact).

Compared structures

  • 1XOS · Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Sildenafil · the same entry in another collection · chain A against A, TM-score 1.00
  • Q07343 · AlphaFold monomer V2.0 prediction for camp-specific 3',5'-cyclic phosphodiesterase 4B… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.